ATG-019 clinical trial application for the treatment of advanced solid tumors and non-Hodgkin's lymphoma was approved in China
Time of Update: 2021-04-13
Deck Pharmaceuticals announced today that the State Food and Drug Administration has approved the application of ATG-019 to start a phase I clinical trial, which aims to evaluate ATG-019
FDA approves the first non-stimulant ADHD therapy in ten years, which is expected to benefit nearly 1 in 10 children
Time of Update: 2021-04-13
A few days ago, Supernus Pharmaceuticals announced that the US FDA has approved the company's Qelbree (viloxazine sustained-release capsules) to be marketed for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 6-17.
Researcher Chen Yongfu's team from Inner Mongolia Agricultural University: Non-targeted fecal
Time of Update: 2021-04-07
metabolism disorder characterized by elevated blood total cholesterol and triglycerides (TGs). Because it is an important risk factor for coronary heart disease, it has caused a major public health
ECH made by hydrogen peroxide method and polycarbonate made by non-phosgene method are selected to encourage foreign investment projects
Time of Update: 2021-03-30
-align: inherit;">22 categories of chemical industries encourage foreign investment, including supporting raw materials for synthetic materials, synthetic fiber raw materials, synthetic rubber, engineering
GUT: Patients with non-alcoholic fatty liver are at increased risk of extrahepatic cancer
Time of Update: 2021-03-30
Stomach cancer pancreatic cancer breast cancer diabetes This large meta-analysis showed that NAFLD is associated with an increased long-term risk of extrahepatic cancer (especially gastrointestinal cancer, breast cancer, and gynecological cancer) in the past 6 years.
NEJM: The effect of subcutaneous injection of semaglutide on non-alcoholic steatohepatitis
Time of Update: 2021-03-30
Thus, the results of this phase 2 clinical trial on patients with NASH showed that the percentage of patients with NASH remission with semaglutide treatment was significantly higher than that of placebo.
[Policy] This province promotes the innovation of non-solvent coating products and reduces VOCs emissions!
Time of Update: 2021-03-29
of the Communist Party of China on winning the battle to defend the blue sky, we will continue to implement air pollution prevention and control actions. By the end of 2020, the concentration of atmospheric particulates will be significantly
Hutchison Pharma enters into an agreement to sell non-core non-prescription drug joint ventures for US$169 million
Time of Update: 2021-03-29
On March 24, Hutchison Medicine announced that it had reached a US$169 million transaction agreement with GL Mountrose Investment Two Limited, which is controlled and managed by Telford Capital.
Can new decoration materials achieve non-zero pollution?
Time of Update: 2021-03-29
="vertical-align: inherit;">It is worth noting that in recent years, the highly respected new decoration material diatom mud, although the sampling pass rate is 100%, all indicators have been detected, which means that the material is not advertised
STROKE AF study: It is also necessary for patients with non-cardiac stroke to undergo long-term cardiac monitoring?
Time of Update: 2021-03-27
Patients with ischemic stroke caused by large atherosclerosis (LAA) or small vessel occlusion (SVO) usually do not receive long-term monitoring of atrial fibrillation (AF), and relevant secondary prevention guidelines do not recommend this approach.
regulatory role of non-coding RNA in the process of plant immunity
Time of Update: 2021-03-27
immune response. In addition, the review also discussed the regulatory role of cross-border mobile small RNAs in the interaction between plants
